C. Rogers

Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate

N. Hansen, W. Gradishar, J. Kim, 2019, Clinical Cancer Research.

Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses

Mark W. Youngblood, Jacob S. Young, Sybren L. N. Maas, 2021, Research square.

Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate

N. Hansen, W. Gradishar, I. Helenowski, 2019, Clinical Cancer Research.

Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses

Mark W. Youngblood, Jacob S. Young, Sybren L. N. Maas, 2023, Research square.